| 注册
首页|期刊导航|中医药学报|中医药防治子宫颈高危型人乳头瘤病毒感染的研究进展

中医药防治子宫颈高危型人乳头瘤病毒感染的研究进展

朱梓齐 林寒梅

中医药学报2025,Vol.53Issue(6):117-120,4.
中医药学报2025,Vol.53Issue(6):117-120,4.DOI:10.19664/j.cnki.1002-2392.250129

中医药防治子宫颈高危型人乳头瘤病毒感染的研究进展

Research Progress on Traditional Chinese Medicine in the Prevention and Treatment of High-Risk Human Papillomavirus(HR-HPV)Infection of the Cervix

朱梓齐 1林寒梅2

作者信息

  • 1. 广西中医药大学,广西 南宁 530001
  • 2. 广西中医药大学第一附属医院,广西 南宁 530022
  • 折叠

摘要

Abstract

Persistent infection with high-risk human papillomavirus(HR-HPV)is a major factor in the development and progression of cervical precancerous lesions and cervical cancer.In recent years,studies on the treatment of cervical HR-HPV infection with traditional Chinese medicine(TCM)have shown unique advantages,providing theoretical support for clinical treatment to prevent the progression to cervical cancer.A review of the literature reveals that the primary mechanisms of action of individual Chinese herbal compounds against HR-HPV include regulation of relevant protein expression,inhibition of inflammatory responses,and induction of apoptosis and autophagy.Compound TCM formulas and external TCM treatments for cervical HR-HPV infection primarily work by alleviating local symptoms of the cervix and vagina,regulating the vaginal microenvironment,enhancing local cervical immunity,and promoting the repair of cervical epithelial cells.These findings provide a reference for further research on the rational use of TCM in treating cervical HR-HPV infection.

关键词

高危型人乳头瘤病毒/中医药/综述

Key words

High-risk human papillomavirus/Traditional Chinese Medicine/Review

分类

医药卫生

引用本文复制引用

朱梓齐,林寒梅..中医药防治子宫颈高危型人乳头瘤病毒感染的研究进展[J].中医药学报,2025,53(6):117-120,4.

基金项目

国家自然科学基金地区科学基金项目(82160919) (82160919)

中医药学报

1002-2392

访问量8
|
下载量0
段落导航相关论文